Asymptomatic Elevation of Amylase and Lipase After Olanzapine
Treatment

J 2016

Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment

USTOHAL, Libor, Michaela MAYEROVÁ, Barbora VALKOVÁ, Hana SEDLÁKOVÁ, Tomáš KAŠPÁREK et. al.

Základní údaje

Originální název

Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment

Autoři

USTOHAL, Libor (203 Česká republika, garant, domácí), Michaela MAYEROVÁ (203 Česká republika, domácí), Barbora VALKOVÁ (203 Česká republika, domácí), Hana SEDLÁKOVÁ (203 Česká republika) a Tomáš KAŠPÁREK (203 Česká republika, domácí)

Vydání

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2016, 0271-0749

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 2.891

Kód RIV

RIV/00216224:14740/16:00090599

Organizační jednotka

Středoevropský technologický institut

DOI

http://dx.doi.org/10.1097/JCP.0000000000000460

UT WoS

000372100800018

Klíčová slova anglicky

ACUTE-PANCREATITIS

Štítky

EL OK, podil, rivok

Změněno: 30. 8. 2016 14:25, Mgr. Eva Špillingová

Anotace

V originále

Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effects of olanzapine are metabolic: acute pancreatitis is one of the most serious adverse effects; fortunately, it does not occur very often. Koller et al1 found 51 cases,and at least 13 cases have been described more precisely. We present a case study of a young female patient with a very fast and high increase of amylase and lipase, who remained asymptomatic, immediately after olanzapine treatment.

Návaznosti

LQ1601, projekt VaV

Název: CEITEC 2020 (Akronym: CEITEC2020)

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CEITEC 2020

Citovat

USTOHAL, Libor, Michaela MAYEROVÁ, Barbora VALKOVÁ, Hana SEDLÁKOVÁ a Tomáš KAŠPÁREK. Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2016, roč. 36, č. 2, s. 181-183. ISSN 0271-0749. Dostupné z: https://dx.doi.org/10.1097/JCP.0000000000000460.

@article{1351896,
   author = {Ustohal, Libor and Mayerová, Michaela and Valková, Barbora and Sedláková, Hana and Kašpárek, Tomáš},
   article_location = {PHILADELPHIA},
   article_number = {2},
   doi = {http://dx.doi.org/10.1097/JCP.0000000000000460},
   keywords = {ACUTE-PANCREATITIS},
   language = {eng},
   issn = {0271-0749},
   journal = {JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY},
   title = {Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment},
   url = {http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx},
   volume = {36},
   year = {2016}
}

TY  - JOUR
ID  - 1351896
AU  - Ustohal, Libor - Mayerová, Michaela - Valková, Barbora - Sedláková, Hana - Kašpárek, Tomáš
PY  - 2016
TI  - Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment
JF  - JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
VL  - 36
IS  - 2
SP  - 181-183
EP  - 181-183
PB  - LIPPINCOTT WILLIAMS & WILKINS
SN  - 02710749
KW  - ACUTE-PANCREATITIS
UR  - http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx
L2  - http://journals.lww.com/psychopharmacology/Citation/2016/04000/Asymptomatic_Elevation_of_Amylase_and_Lipase_After.18.aspx
N2  - Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effects of olanzapine are metabolic: acute pancreatitis is one of the most serious adverse effects; fortunately, it does not occur very often. Koller et al1 found 51 cases,and at least 13 cases have been described more precisely. We present a case study of a young female patient with a very fast and high increase of amylase and lipase, who remained asymptomatic, immediately after olanzapine treatment.
ER  -

USTOHAL, Libor, Michaela MAYEROVÁ, Barbora VALKOVÁ, Hana SEDLÁKOVÁ a Tomáš KAŠPÁREK. Asymptomatic Elevation of Amylase and Lipase After Olanzapine Treatment. \textit{JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY}. PHILADELPHIA: LIPPINCOTT WILLIAMS \&{} WILKINS, 2016, roč.~36, č.~2, s.~181-183. ISSN~0271-0749. Dostupné z: https://dx.doi.org/10.1097/JCP.0000000000000460.

Podrobný výpis o publikaci